PsychoGenics
PsychoGenics is a biotechnology company focused on AI-enabled phenotypic drug discovery. They utilize proprietary platforms like eCube to identify novel applications for existing drugs, targeting rare diseases with limited treatment options. Their approach involves repurposing existing drugs and evaluating them using advanced machine learning and various mouse models.
Funding Round: Grant
Funding Amount: $3M
Date: 28-Aug-2024
Investors: NIMH
Markets: Biotechnology, AI, Drug Discovery, Rare Disease Treatment, Research Services, Health Care, Medical
HQ: Paramus, New Jersey, United States
Founded: 1999
Website: https://www.psychogenics.com/
LinkedIn: https://www.linkedin.com/company/psychogenicsinc
Crunchbase: https://www.crunchbase.com/organization/psychogenics
Leave a Comment
Comments
No comments yet.